The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative which could ...

Medical device distribution giant Medline was slammed for a second time since April by an FDA warning letter that chided the ...

The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. | The drumbeat of news regarding ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government ...

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...

Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...

In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Fierce Pharma’s Zoey Becker and Angus Liu ...

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...

Amid shifts in attitudes around family planning and contraception—and as the advent of telehealth outfits like Hims & Hers ...

It’s the moment of truth for Akeso’s ivonescimab, and to many, a high-stakes test for China’s booming biotech industry. | ...

After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate ...